Last Updated : April 13, 2004
Details
FilesGeneric Name:
Mixed amphetamine salts
Project Status:
Complete
Therapeutic Area:
Attention deficit hyperactivity disorder
Manufacturer:
Shire BioChem Inc.
Brand Name:
Adderall XR
Project Line:
Reimbursement Review
Project Number:
SR0010-000
Submission Type:
Initial
Indications:
Attention deficit hyperactivity disorder
Recommendation Type:
Do not list
Final Recommendation:
Recommendation:
Not to list.
Files
Last Updated : April 13, 2004